Vimian Group AB

Capital/Financing Update • May 13, 2025

Vimian successfully issues senior unsecured bonds of EUR 150 million

Vimian Group AB ("Vimian") has successfully issued new senior unsecured bonds (the "Bonds" and the "Bond Issue", respectively) of EUR 150 million with a tenor of three years, within a framework of EUR 250 million. The Bonds will carry a floating interest of EURIBOR 3m plus 200 basis points per annum.

The settlement date of the Bond Issue is expected to occur on 22 May 2025. The Bond Issue saw strong demand from a broad base of investors and was significantly oversubscribed. Vimian intends to apply for admission to trading of the Bonds on the corporate bond list of Nasdaq Stockholm.

DNB Carnegie Investment Bank AB (publ), Nordea Bank Abp, and Skandinaviska Enskilda Banken AB (publ) acted as joint bookrunners in connection with the Bond Issue. Mannheimer Swartling acted as legal advisor to the joint bookrunners and Vinge acted as legal advisor to Vimian.

For further information, please contact:

Carl-Johan Zetterberg Boudrie CFO carl-johan.zetterberg@vimian.com +46 70 335 84 49

About Vimian

Vimian is a global animal health company covering four essential and rapidly evolving areas: Specialty Pharma, MedTech, Veterinary Services and Diagnostics. At Vimian, we believe that every animal deserves the best available care. We bring pioneering and entrepreneurial businesses together to make the market's most innovative offerings accessible to more animal health professionals and pet owners. Headquartered in Stockholm, Sweden, Vimian reaches over 17,000 veterinary clinics and laboratories, sells to over 80 markets, has 1,200 employees and annual revenues of approximately EUR 375 million. For more information, please visit: www.vimian.com.

Attachments

Vimian successfully issues senior unsecured bonds of EUR 150 million